Cargando…
Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice
The human CD98 heavy chain (CD98hc) offers a promising biomedical target both for tumor therapy and for drug delivery to the brain. We have previously developed a cognate Anticalin protein with picomolar affinity and demonstrated its effectiveness in a xenograft animal model. Due to the lack of cros...
Autores principales: | Deuschle, Friedrich‐Christian, Schiefner, André, Brandt, Corinna, Skerra, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380666/ https://www.ncbi.nlm.nih.gov/pubmed/32463547 http://dx.doi.org/10.1002/pro.3894 |
Ejemplares similares
-
Development of a high affinity Anticalin(®) directed against human CD98hc for theranostic applications
por: Deuschle, Friedrich-Christian, et al.
Publicado: (2020) -
Anticalin(®) Proteins as Therapeutic Agents in Human Diseases
por: Rothe, Christine, et al.
Publicado: (2018) -
Structure of the human heterodimeric transporter 4F2hc-LAT2 in complex with Anticalin, an alternative binding protein for applications in single-particle cryo-EM
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2022) -
High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide
por: Rauth, Sabine, et al.
Publicado: (2016) -
Engineering a Highly Active Sucrose Isomerase for Enhanced Product Specificity by Using a “Battleship” Strategy
por: Pilak, Patrick, et al.
Publicado: (2020)